| Identification | Back Directory | [Name]
5-BROMO-2-(2-METHYL-2H-TETRAZOL-5-YL)-PYRIDINE
| [CAS]
380380-64-3 | [Synonyms]
Torezolid-11
Tedizolid Impurity 67
Tedizolid interMediate
Torezolid Intermediate2
Methyl-5- (5-bromo-2-yl) tetrazole
2-(2-Methyl-5-tetrazolyl)-5-bromopyridine
2-methyl-5-(5-bromopyridine-2-yl) tetrazolium
Pyridine, 5-broMo-2-(2-Methyl-2H-tetrazol-5-yl)-
5-broMo-2-(2-Methyl-2H-tetrazol-5-yl)pyridine (c)
5-bromo-2-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)pyridine
5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine380380-64-3
5-BROMO-2-(2-METHYL-2H-TETRAZOL-5-YL)-PYRIDINE ISO 9001：2015 REACH | [Molecular Formula]
C7H6BrN5 | [MDL Number]
MFCD06796604 | [MOL File]
380380-64-3.mol | [Molecular Weight]
240.07 |
| Chemical Properties | Back Directory | [Boiling point ]
375.2±52.0 °C(Predicted) | [density ]
1.85±0.1 g/cm3 (20 ºC 760 Torr) | [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
soluble in Dichloromethane | [form ]
Solid | [pka]
0.94±0.10(Predicted) | [color ]
White | [InChI]
InChI=1S/C7H6BrN5/c1-13-11-7(10-12-13)6-3-2-5(8)4-9-6/h2-4H,1H3 | [InChIKey]
JANKGNBDRWYWSN-UHFFFAOYSA-N | [SMILES]
C1(C2=NN(C)N=N2)=NC=C(Br)C=C1 |
| Hazard Information | Back Directory | [Uses]
5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine-d3 is an intermediate in synthesizing Tedizolid-d3 (T013752), a labelled form of Tedizolid, known as TR-700, which is an oral and i.v administered intracellular antibacterial drug. | [Synthesis]
1. 5-Bromo-2-(2H-tetrazol-5-yl)pyridine (226 g), formaldehyde (90 g) and 10% palladium-carbon catalyst (20 g) were added to a reactor in 1.5 L of methanol. 2. The reaction was stirred at room temperature under hydrogen atmosphere (0.2 MPa) for 3 h. 3. Upon completion of the reaction, the organic phase was removed by evaporation. 4. The residue was recrystallized using acetonitrile to afford the target product 2-methyl-5-(5-bromo-2-pyridinyl)tetrazole (217 g) in 90.4% yield. | [References]
[1] Patent: CN106632240, 2017, A. Location in patent: Paragraph 0018-0019 |
|
|